Have you already asked yourself what happens after your medicinal product has been approved in Switzerland? What steps are necessary for market access or to obtain health insurance approval? New medicinal products are included in the Specialty List (SL) if they meet the assessment of efficacy, appropriateness and cost-effectiveness (WZW criteria). We help you to find your way around the processes and procedures published in the administrative ordinances of the Federal Office of Public Health (FOPH).